M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection
- PMID: 22649518
- PMCID: PMC3359358
- DOI: 10.1371/journal.pone.0037314
M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection
Abstract
Indoleamine 2,3-dioxygenesae-1 (IDO-1) catalyses the initial, rate-limiting step in tryptophan metabolism, thereby regulating tryptophan availability and the formation of downstream metabolites, including picolinic and quinolinic acid. We found that Mycobacterium tuberculosis infection induced marked upregulation of IDO-1 expression in both human and murine macrophages in vitro and in the lungs of mice following aerosol challenge with M. tuberculosis. The absence of IDO-1 in dendritic cells enhanced the activation of mycobacteria-specific T cells in vitro. Interestingly, IDO-1-deficiency during M. tuberculosis infection in mice was not associated with altered mycobacteria-specific T cell responses in vivo. The bacterial burden of infected organs, pulmonary inflammatory responses, and survival were also comparable in M. tuberculosis-infected IDO-1 deficient and wild type animals. Tryptophan is metabolised into either picolinic acid or quinolinic acid, but only picolinic acid inhibited the growth of M. tuberculosis in vitro. By contrast macrophages infected with pathogenic mycobacteria, produced quinolinic, rather than picolinic acid, which did not reduce M. tuberculosis growth in vitro. Therefore, although M. tuberculosis induces robust expression of IDO-1 and activation of tryptophan metabolism, IDO-1-deficiency fails to impact on the immune control and the outcome of the infection in the mouse model of tuberculosis.
Conflict of interest statement
Figures







Similar articles
-
Beneficial or detrimental activity of regulatory T cells, indoleamine 2,3-dioxygenase, and heme oxygenase-1 in the lungs is influenced by the level of virulence of Mycobacterium tuberculosis strain infection.Front Cell Infect Microbiol. 2023 May 22;13:1105872. doi: 10.3389/fcimb.2023.1105872. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37284503 Free PMC article.
-
Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality.Blood. 2009 Dec 3;114(24):5062-70. doi: 10.1182/blood-2009-06-227587. Epub 2009 Oct 14. Blood. 2009. PMID: 19828695 Free PMC article.
-
Indoleamine-2,3-dioxygenase inhibition improves immunity and is safe for concurrent use with cART during Mtb/SIV coinfection.JCI Insight. 2024 Jul 2;9(15):e179317. doi: 10.1172/jci.insight.179317. JCI Insight. 2024. PMID: 39114981 Free PMC article.
-
Indoleamine 2, 3-Dioxygenase-Mediated Tryptophan Catabolism: A Leading Star or Supporting Act in the Tuberculosis and HIV Pas-de-Deux?Front Cell Infect Microbiol. 2019 Oct 29;9:372. doi: 10.3389/fcimb.2019.00372. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31737575 Free PMC article. Review.
-
Molecules in focus: indoleamine 2,3-dioxygenase.Int J Biochem Cell Biol. 2007;39(12):2167-72. doi: 10.1016/j.biocel.2007.01.004. Epub 2007 Jan 20. Int J Biochem Cell Biol. 2007. PMID: 17320464 Review.
Cited by
-
Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives.Cells. 2020 Jun 26;9(6):1564. doi: 10.3390/cells9061564. Cells. 2020. PMID: 32604956 Free PMC article. Review.
-
Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway.Front Immunol. 2019 Nov 6;10:2570. doi: 10.3389/fimmu.2019.02570. eCollection 2019. Front Immunol. 2019. PMID: 31781097 Free PMC article. Review.
-
Animal models for COVID-19 and tuberculosis.Front Immunol. 2023 Aug 11;14:1223260. doi: 10.3389/fimmu.2023.1223260. eCollection 2023. Front Immunol. 2023. PMID: 37638020 Free PMC article. Review.
-
Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate Vaccination.Front Immunol. 2016 Dec 16;7:577. doi: 10.3389/fimmu.2016.00577. eCollection 2016. Front Immunol. 2016. PMID: 28018344 Free PMC article. Review.
-
Interleukin-18, Functional IL-18 Receptor and IL-18 Binding Protein Expression in Active and Latent Tuberculosis.Pathogens. 2020 Jun 8;9(6):451. doi: 10.3390/pathogens9060451. Pathogens. 2020. PMID: 32521630 Free PMC article.
References
-
- Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581–620. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials